Efficacy, Safety, and Dosing of an Oral Treatment Option for Active Psoriatic Arthritis

Innovation Theater B | Supported By: Bristol Myers Squibb

Program Description

Please join us for a discussion of an oral systemic treatment for adults with active psoriatic arthritis. This program covers key efficacy data in treating active psoriatic arthritis along with safety data and information on dosing and administration.

Speakers

Presenter: Philip Mease, MD
Swedish Health Services
Board-certified rheumatologist
Seattle, Washington